Bibliografía del artículo
1. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 12(1):53-72, 2001.
2. El-Masry S, Lotfy M, Nasif WA, El-Kady IM, Al-Badrawy M. Elevated serum level of interleukin (IL)-18, interferon (IFN)-gamma and soluble Fas in patients with pulmonary complications in tuberculosis. Acta Microbiol Immunol Hung 54(1):65-77, 2007.
3. Budak F, Uzaslan EK, Cangur S, Goral G, Oral HB. Increased pleural soluble Fas ligand (sFasL) levels in tuberculosis pleurisy and its relation with T-helper type 1 cytokines. Lung 186(5):337-343, 2008.
4. Smith J, Manoranjan J, Pan M et al. Evidence for pore formation in host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape from vacuole. Infect Immun 76(12):5478-5487, 2008.
5. Yamamoto N, Murata K, Yoneda K et al. Protective role of interleukin-18 against Fas-mediated liver injury. Int J Mol Med 22(1):43-48, 2008.
6. Lochner M, Kastenmuller K, Neuenhahn M et al. Decreased susceptibility of mice to infection with Listeria monocytogenes in the absence of interleukin-18. Infect Immun 76(9):3881-3890, 2008.
7. Delogu G, Famularo G, Tellan G et al. Lymphocyte apoptosis, caspase activation and inflammatory response in septic shock. Infection 36(5):485-487, 2008.
8. Roetman B, Schinkel C, Wick M, Frangen T, Muhr G, Koller M. Elevated systemic interleukin-18 in multiple injured patients is not related to clinical outcome. J Interferon Cytokine Res 28(12):741-747, 2008.
9. Yu JT, Tan L, Song JH et al. Interleukin-18 promotor polymorphisms and risk of late onset Alzheimer's disease. Brain Res 1253:169-175, 2009.
10. Kim CD, Ryu HM, Choi HJ et al. Association of G-137C IL-18 promotor polymorphism with acute allograft rejection in renal transplant recipients. Transplantation 86(11):1610-1614, 2008.
11. Harishankar M, Selvaraj P, Rajeswari DN, Anand SP, Narayanan PR. Promotor polymorphism of IL-18 gene in pulmonary tuberculosis in South Indian population. Int J Immunogenet 34(5):317-320, 2007.
12. Sada-Ovalle I, Chiba A, Gonzales A, Brenner MB, Behar SM. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PloS Pathol 4:e1000239, 2008.
13. Suguwara I, Yamada H, Mizuno S, Li CY, Nakayama T, Taniguchi M. Mycobacterial infection in natural killer T cell knockout mice. Tuberculosis 82(2-3):97-104, 2002.
14. Kawakami K, Kinjo Y, Uezu K et al. Minimal contribution of Valpha14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice. Microbiol Immunol 46(3):207-210, 2002.
15. Ren T, Liang YJ, Cai YY et al. a study on the mechanisms of mycobacterial clearance induced by CpG-oligodeoxynucleotides in mice. Zhonghua Jie He He Hu Xi Za Zhi 31(1):46-50, 2008.
16. Sharma M, Sharma S, Roy S, Varma S, Bose M. Pulmonary epithelial cells are a source of interferon-gamma in response to Mycobacterium tuberculosis infection. Immunol Cell Biol 85(3):229-237, 2007.
17. Kulpraneet M, Sukwit S, Sumransurp K, Chuenchitra T, Santiwatanakul S, Srisurapanon S. Cytokine production in NK and NKT cells from Mycobacterium tuberculosis infected patients. Southeast Asian J Trop Med Public Health 38(2):370-375, 2007.
18. Kwiatkowska S, Piasecka G, Zieba M, Piotrowski W, Nowak D. Increased serum concentrations of conjugated diens and malondialdehyde in patients with pulmonary tuberculosis. Respir Med 93(4):272-276, 1999.
19. Selek S, Cosar N, Kocyigit A. PON1 activity and total oxidant status in patients with active pulmonary tuberculosis. Clin Biochem 41(3):140-144, 2008.
20. Lamsal M, Gautam N, Bhatta N, Toora BD, Bhattacharya SK, Baral N. Evaluation of lipid peroxidation product, nitrite and antioxidant levels in newly diagnosed and two months follow-up patients with pulmonary tuberculosis. Southeast Asian J Trop Med Public Health 38(4):695-703, 2007.
21. Seyedrezazadeh E, Ostadrahimi A, Mahboob S, Assadi Y, Ghaemmagami J, Pourmogaddam M. Effect of vitamin E and selenium supplementation on oxidative stress status in pulmonary tuberculosis patients. Respirology 13(2):294-298, 2008.
22. Pagan-Ramos E, Master SS, Pritchett CL et al. Molecular and physiological effects of mycobacterial oxyR inactivation. J Bacteriol 188(7):2674-2680, 2006.
23. Bhadauria S, Singh G, Sinha N, Srivastava S. Isoniazid induces oxidative stress, mitochondrial dysfunction and apoptosis in Hep G2 cells. Cell Mol Biol 53(1):102-114, 2007.
24. Koo IC, Wang C, Raghavan S, Morisaki JH, Cox JS, Brown EJ. ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection. Cell Microbiol 10(9):1866-1878, 2008.
25. Smith J, Manoranjan J, Pan M et al. Evidence for pore formation in host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape from vacuole. Infect Immun 76(12):5478-5487, 2008.
26. Ganguly N, Giang PH, Gupta C et al. Mycobacterium tuberculosis secretory proteins CFP-10, ESAT-6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide-induced NF-kappaB transactivation by downregulation of reactive oxidative species (ROS) production. Immunol Cell Biol 86(1):98-106, 2008.
27. Darwich L, Coma G, Pena R et al. Secretion of interferon- by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18. Immunology 126(3):386-393, 2008.
28. Kwiatkowska S, Szkudlarek U, Luczynska M, Nowak D, Zieba M. Elevated exhalation of hydrogen peroxide and circulating IL-18 in patients with pulmonary tuberculosis. Respir Med 101(3):574-580, 2007.
29. Puren AJ, Fantuzzi G, Gu Y, Su MS, Dinarello CA. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Investig 101(3):711-721, 1998.
30. Canetti CA, Leung BP, Culshaw S, McInnes IB, Cunha FQ, Liew FY. IL-18 enhances collagen-induced arthritis by recruiting neutrophils via TNF-alpha and leukotriene B4. J Immunol 171(2):1009-1015, 2003.
31. Sporri R, Joller N, Hilbi H, Oxenius A. A novel role for neutrophils as critical activators of NK cells. I Immunol 181(10):7121-7130, 2008.
32. Mahan CS, Thomas JJ, Boom WH, Rojas RE. CD4(+)CD25(high)Foxp3(3+) regulatory T cells downregulate human Vdelta2(+) T-lymphocyte function triggered by anti-CD3 or phosphoantigen. Immunology, published online, 2008.
33.Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4(4):330-336, 2003.
34. Yagi H, Nomura T, Nakamura K et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 16(11):1643-1656, 2004.